Dichotomizing ATTR-CA Into Neurologic and Cardiac Phenotypes Is So 2010..What Works For One Works For the Other

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Study investigator, consultant - Alnylam Pharmaceuticals; AstraZeneca/Ionis Pharmaceutical; Eidos/BridgeBio
• Consultant - Intellia Therapeutics